Stem Cells Int. 2017;2017:6061729. doi: 10.1155/2017/6061729. Epub 2017 Nov 9.

Human Mesenchymal Stem/Stromal Cells from Umbilical Cord Blood and Placenta Exhibit Similar Capacities to Promote Expansion of Hematopoietic Progenitor Cells In Vitro.

Fajardo-Orduña GR¹, Mayani H², Flores-Guzmán P², Flores-Figueroa E³, Hernández-Estévez E¹, Castro-Manrreza M⁴, Piña-Sánchez P⁵, Arriaga-Pizano L⁶, Gómez-Delgado A⁷, Alarcón-Santos G⁸, Balvanera-Ortíz O⁸, Montesinos JJ¹.

Abstract

Mesenchymal stem/stromal cells (MSCs) from bone marrow (BM) have been used in coculture systems as a feeder layer for promoting the expansion of hematopoietic progenitor cells (HPCs) for hematopoietic cell transplantation. Because BM has some drawbacks, umbilical cord blood (UCB) and placenta (PL) have been proposed as possible alternative sources of MSCs. However, MSCs from UCB and PL sources have not been compared to determine which of these cell populations has the best capacity of promoting hematopoietic expansion. In this study, MSCs from UCB and PL were cultured under the same conditions to compare their capacities to support the expansion of HPCs in vitro. MSCs were cocultured with CD34⁺CD38^-Lin^- HPCs in the presence or absence of early acting cytokines. HPC expansion was analyzed through quantification of colony-forming cells (CFCs), long-term culture-initiating cells (LTC-ICs), and CD34⁺CD38^-Lin^- cells. MSCs from UCB and PL have similar capacities to increase HPC expansion, and this capacity is similar to that presented by BM-MSCs. Here, we are the first to determine that MSCs from UCB and PL have similar capacities to promote HPC expansion; however, PL is a better alternative source because MSCs can be obtained from a higher proportion of samples.